Canadian Markets closed

Ceapro Inc. (CZO.V)

TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.58-0.01 (-1.69%)
At close: 3:23PM EDT
People also watch
CRH.TOBUS.VPHO.VPHM.VRX.V
Full screen
Previous Close0.59
Open0.58
Bid0.59 x 0
Ask0.60 x 0
Day's Range0.58 - 0.60
52 Week Range0.55 - 2.02
Volume63,250
Avg. Volume81,350
Market Cap43.72M
Beta4.52
PE Ratio (TTM)38.67
EPS (TTM)0.01
Earnings DateNov 21, 2017 - Nov 27, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Ceapro, Inc.: Sudden move in price, will it continue?
    Capital Cube20 days ago

    Ceapro, Inc.: Sudden move in price, will it continue?

    Categories: Yahoo FinanceCeapro, Inc. relative valuation is UNDERVALUED and it has a fundamental analysis score of 84. Our analysis is based on comparing Ceapro, Inc. with the following peers – Microbix Biosystems Inc., ProMetic Life Sciences Inc., GeneNews Limited, Medicure Inc., Sirona Biochem Corp., Med BioGene Inc., Critical Outcome Technologies Inc. and Generex Biotechnology Corporation (MBX-CA, PLI-CA, ... Read more (Read more...)

  • Ceapro, Inc. :CZO-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 22, 2017
    Capital Cube28 days ago

    Ceapro, Inc. :CZO-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 22, 2017

    Categories: Yahoo FinanceGet free summary analysis Ceapro, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Ceapro, Inc. – ProMetic Life Sciences Inc., GeneNews Limited and Medicure Inc. (PLI-CA, GEN-CA and MPH-CA) that have also reported for this period. Highlights Summary numbers: Revenues of CAD ... Read more (Read more...)

  • Marketwiredlast month

    Ceapro Reports 2017 Second Quarter Business Update and Financial Results

    Ceapro Inc. a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today its financial results for ...